Search

everythinglearnresearchcommunity

for

Search:↓

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

The study concluded that the most common skin problems in women with PCOS are excess hair, acne, oily skin, hair loss, dark skin patches, and skin tags.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Androgens affect the function and health of the endometrium.

PCOS is linked to low-grade chronic inflammation.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.